Advisors Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-70,029
| Closed | -$1.41M | – | 1534 |
|
|
2021
Q3 | $1.41M | Buy |
70,029
+22,425
| +47% | +$452K | 0.02% | 709 |
|
|
2021
Q2 | $1.78M | Buy |
47,604
+38,384
| +416% | +$1.43M | 0.03% | 633 |
|
|
2021
Q1 | $236K | Sell |
9,220
-233
| -2% | -$5.96K | ﹤0.01% | 1182 |
|
|
2020
Q4 | $208K | Buy |
9,453
+694
| +8% | +$15.3K | ﹤0.01% | 1213 |
|
|
2020
Q3 | $158K | Buy |
8,759
+4,057
| +86% | +$73.2K | ﹤0.01% | 1232 |
|
|
2020
Q2 | $119K | Buy |
+4,702
| New | +$119K | ﹤0.01% | 1267 |
|